chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 12/29/21 around 6pm two family member arrived at the pharmacy with their parent for their scheduled 2nd covid-19 vaccines. This day was a very busy day from the very beginning and  throughout the whole day, I was doing my very best to manage the flow within the pharmacy given the high volume of patients at drop off, pick-up, counseling, and immunization appointments. When they arrived to the pharmacy for their appointment, we checked both patients in at the drop-off window. They then went through the normal screening procedure before getting the vaccine. Once they were checked-in, they were put in the immunization room with their parent (mother). I then took both patient forms and confirmed all the details on the form with the mother of the two patients. One was 12 years old and the other was 9 years old. Then I proceeded to prepared both vaccines. Once the vaccines were made, I came back into the immunization room with the vaccines ready. Both patients looked very alike in terms of height and body features. When came the time to administer the vaccine, I was under the impression that the mom had told me to go ahead and administered the 12 years old first which led me to get the "adult Pfizer vaccine" and administer it. I proceeded to administer the "adult Pfizer vaccine" to the 9 years old thinking that I was in fact giving the vaccine to the 12 years old patient given the similarities in body features. But then I realized that I had given the wrong vaccine to the wrong patient. Instead of the "pediatric Pfizer vaccine", I had given the "Adult Pfizer vaccine" to the 9 year old.  Immediately after administration, I informed the mother. The mother was understanding of the situation. I asked the family to stay around for 15 minutes in the room to make sure that everything was ok before they left. When they were leaving, the 9 years old patient  was feeling ok. I then followed up with the mom a couple hours after to make sure everything was ok with the patient. I then also proceeded to contact Pfizer but their medical department was already closed for the day. I will follow-up with Pfizer again and I also plan on following up with the patient's doctor.
Mild headache at first. Several days later a moderate headache and then a week after the vaccine was a full blown migraine with severe light sensitivity. I?ve had daily migraines that keep me from working for four weeks now. No end in sight. Just keeps getting worse. I ended up in the ER a couple days ago the pain was so bad.
Information has been received from a physician referring to an unspecified number of unspecified patients. No medical history or concurrent conditions were included. Since 06-SEP-2016, the patients had been administered doses of ROTATEQ (lot#, expiration date, dose, route unspecified) which were improperly stored. No adverse effects reported. This is one of the reports received from the same reporter. Additional information has been requested.
Headache , dizziness, neck pain, left flank pain, fever 100.2 , chills,fatigue and muscle aches.
syncope, paleness, flushed - laid patient on back feet up tracked vitals, rest, slowly into sitting position given water and pedialyte ice pop, vitals stable and patient left in stable condition with mother and sister,
On 1/22 5 PM noted "red and hives", fussy. Did not progress to respiratory signs and symptoms. "Redness & hives" progressed to entire body. Mom contacted Dr who recommended Cortisone cream, applied. Didn't have Benadryl. Seen by Dr on 1/22, Histinex and calamine lotion prescribed. Resolved by 9:20 AM 1/26.
Tetanus Vaccine was given to a qualified donor and he immediately felt dizzy, sweaty, and lightheaded. After a nurse provided comfort care (ice pack), oral fluids and  a snack, the donor felt much better. Donor's vitals remained stable and donor left the facility in good condition around 2:10pm.
Pr (R) arm reacted with red spots around injected area. Pt was given BENADRYL 10 mg per dr.
7/23/04: chicken pox vaccine. 7/25/04: broke out in rash on arms, legs, buttock. 7/27/04: Benadryl and Tylenol for 2.5 days. 7/30/04: scabs present, drying up.
Patient is 45 y/o. Based on lot number she received a pediatric dose in error, not the reccomended/needed adult dose.
feeling nausea; vertigo; felt a bit dizzy; booster; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 02Dec2021 (Batch/Lot number: unknown) at the age of 45 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: INFLUENZA taken for immunisation, administration date 25Nov2021. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown), administration date: 31Mar2021, when the patient was 44 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown), when the patient was 44 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 02Dec2021, outcome "unknown", described as "booster"; NAUSEA (non-serious) with onset 02Dec2021 12:00, outcome "recovered" (Dec2021), described as "feeling nausea"; VERTIGO (non-serious) with onset 02Dec2021, outcome "recovered" (Dec2021), described as "vertigo"; DIZZINESS (non-serious) with onset 02Dec2021, outcome "recovered" (Dec2021), described as "felt a bit dizzy". Therapeutic measures were taken as a result of nausea, vertigo, dizziness. Additional information: No known allergies. Three days after patient received the 3rd dose she woke up feeling nauseas and had vertigo. Patient was in bed the entire day the next day she felt a bit dizzy. Treatment included meclizine 12.5 mg. No covid prior vaccination. No covid tested post vaccination.  The lot number for bnt162b2 was not provided and will be requested during follow up.
I just felt tingling in my head and shoulders initially but within 1/2 hour my whole boddy felt tingly...within a few hours I had a mild headache and inability to think well so had to cancel meetings and planned events.  I think I'll switch to Pfizer next time.
Fever - Temperature of 99.7F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever - Temperature of 99.7F) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PYREXIA (Fever - Temperature of 99.7F). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever - Temperature of 99.7F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Body temperature: 99.7 f (High) 99.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Extreme nerve pain, extreme body aches, violent migraines, extreme diarrhea from midnight to 6 am, difficulty walking, hot flashes, cold flashes, congestion, high fatigue, difficulty sleeping due to high painand difficulty standing due to light headiness.
Pt. returned to clinic after experiencing difficulty breathing and throat tightness approx. 2-3 hours after Zostavax vaccine.
I was on a backpacking hike on the AT and had a great hike the evening before the event. The next morning, I couldn't hike more than 5 steps up all the gentle inclines & had to stop & try to catch my breath. This happened throughout the morning until I was able to get off trail. I am a former ultra marathon runner & long distance hiker. I've hiked the trails at high altitude & snowy passes without ever having an issue such as this one. The next day, I was able to continue unimpeded. A very strange occurrence. I'm late in reporting this, as I originally didn't attribute this to the vaccine, but now feel this may be the contributing factor.
No adverse reaction occurred. COVID vaccine was administered on 11/14/22 when the patient was 5 months and 25 days, 6 days prior to the authorized starting age for COVID-19 vaccines. Reported spoke with CDC on 12/16/22 and was recommended not to repeat dose until patient reaches authorized age and to delay second dose until 8 weeks after invalid dose was administered.
This initial spontaneous case, was received from nurse on 25-Oct-2017, concerning a 63-year-old adult female patient. The patient's historical conditions included: had a titanium cobalt hip implant (about 3 years ago). The patient got a reaction and developed the asthmatic-like symptoms. She was treated but the treatment did not work and hence removal of implant was done. The history of asthma was only during the time she had the implant. All the asthmatic symptoms were resolved in 2015. It was reported that she never had any reactions to any other vaccine. The patient's current conditions included asthma and hypothyroidism (since an unspecified date). The patient's concomitant medications included Levothyroxine and EVISTA for an unknown indication. The patient did not have any known allergy. On 18-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, batch number: 195245, expiry date; Jun-2018, route of administration: intramuscular, anatomical location: deltoid). On the same day, about 1 hour after vaccination, the patient developed itching, rash, hives, swollen lip and went to the emergency room, she had also had shortness of breath and developed full body rash, which resolved with BENADRYL, SOLUMEDROL, Fluids via intravenous route and PEPCID, but she had little bit of rash left at bra line and patient was discharged home. It was reported that, she woke up and noticed full body rash again and areas of blisters over the entire body. At that point, she called the emergency room and started an unspecified oral steroids and antihistamines, which was completely resolved on an unspecified date. The reporter suspected that, she was allergic to metals and advised to stop using jewelry. The outcome of the events was recovered. The reporter assessed the report as serious (medically significant). Follow-up report received from the nurse on 13-Nov-2017: Outcome of the events "Generalized rash and blistering" was changed from recovering to recovered. It was reported that, the patient had no inpatient hospitalization but only emergency visit. The nurse did not know, if the patient had any previous allergic reactions. Amended narrative accordingly. Follow-up report received from the nurse on 29-Nov-2017: Updated medical history. The patient had a titanium cobalt hip implant (about 3 years ago). The patient got a reaction and developed asthmatic-like symptoms. She was treated but the treatment did not work and hence removal of implant was done. The history of asthma was only during the time she had the implant. All the asthmatic symptoms were resolved in 2015. It was reported that she never had any reactions to any other vaccine. The narrative was amended accordingly.
Got the flu shot and guess what, I got the flu; Initial information received on 13-Dec-2022 regarding an unsolicited valid non-serious case via consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who stated got the flu shot and guess what, i got the flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer unknown at this time (strength, form, batch lot, expiry date: unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient had a non-serious event of got the flu shot and guess what, i got the flu (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event.  Outcome: Unknown.
Initial normal redness and tenderness of injection site (about size of silver dollar) cleared after several days, but on evening of day 9 (1/25/21),  large round redness, with hardness and heat suddenly reappeared and expanded.  Given history of cellulitis, I consulted primary care physicians office and was seen 1/26/21.  Agreed to treat with antibiotic cephalexin if perimeter still expanding by morning of 1/17/21, which it was.  After 48 hours on antibiotic, looking much better, but itchy. Advised today to stop antibiotic as medical clinic has become aware of "Covid Arm" rash in USA Today article, and I was advised to report this event to VAERS.  Now suspecting this is delayed rash not cellulitis.  Will prep right arm for #2 vaccine on 2/13/21 with ChloraPrep and monitor.
shortness of breath; fatigue; back pain; This is a spontaneous report from a contactable Other Health Professional (patient). A 50-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Patient age at vaccination was 50 years old. The patient medical history and concomitant medications were not reported.  Patient experienced fatigue and back pain. Patient also experienced shortness of breath and used salbutamol (ALBUTEROL). Stated she used the "machine you put the stuff in". Outcome of the events was unknown.  Information about lot/batch number has been requested.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Unknown Result. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that the patient received Anti-viral treatment for COVID 19 in 2 weeks after vaccine administration.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The company cannot completely exclude the possible causality between the reported COVID-19, which is considered as failure of vaccine BNT162B2, and the administration of BNT162B2, as the efficacy of a vaccine varies individually and may be affected by different factors including drug potency.
sudden onset pain left armpit radiating down to elbow and into left breast and back.   Severe.  Treated at ER with percoset and turadol and aspirin.  Tested for blood clots, heart attack, lymph node anomaly.   Everything tested came back as normal.  Sent home.  Used naproxen and hydrocodone and ice at home.  discomfort continues but is bearable now (next day) with drugs and ice.    Note:  Took monthly Cosentyx shot on Feb 20, 2021.
Information has been received from an 87 year old male patient with eye disorder, "heart case" and "a certain sense to Algerian ivy" who in the middle of September 2010, was vaccinated with ZOSTAVAX (Merck) (lot# not reported) intramuscularly at one time. Concomitant therapy included XALATAN for eyes. The patient reported that he had shingles in August 2010 where he broke out in sores and had an itch on the right side above his hip up to the nipple. On 15-DEC-2010 the patient had sores again and an itch, but this time around his hips, above the nipple and on his back and waist. The patient also reported that XALATAN gave him blurry vision but he still used it. The patient "just came off anemia study" and the result was not reported. At the time of reporting, the outcome of the events was not reported. The patient was given no treatment and sought unspecified medical attention. No further information is available.
approx 20-30 mins p/vax pt c/o sweaty palms, tightness in throat; pt referred to urgent care facility
Drug ineffective; COVID-19; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Apr2022 as dose 4 (booster), single (Lot number: FJ6369) at the age of 71 years, in right arm for covid-19 immunisation; davesomeran, elasomeran (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), on 21Sep2022 as dose 5 (booster), single (Lot number: AS71445B), in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 15Jan2021 as dose 1, single (Lot number: 013L20A), in right arm, on 11Feb2021 as dose 2, single (Lot number: 039K20A), in right arm and on 10Sep2021 as dose 3 (booster), single (Lot number: 062E21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "cancer on chemo therapy" (unspecified if ongoing), notes: cancer on chemo therapy; "kidney disease" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 29Apr2022, outcome "unknown"; COVID-19 (medically significant) with onset 2023, outcome "unknown"; DRUG INEFFECTIVE (medically significant) with onset 2023, outcome "unknown". The patient underwent the following laboratory tests and procedures: Body temperature: 101 Fahrenheit; SARS-CoV-2 test: Positive; Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Treatment of Paxlovid started on 23Feb2023 an stopped on 28Feb2023.; Sender's Comments: Considering a plausible drug-event temporal association, a reasonable possibility that the events interchange of vaccine products, Covid-19, and drug ineffective are related to  BNT162b2 cannot be excluded. This case will be reassessed should additional information become available.,Linked Report(s) : US-PFIZER INC-202300107465 Same patient, different drug and event;
Prolonged systemic side-effects. >5 days of severe fatigue (in bed >8 hours per day) and moderate headache without improvement.
Woken up by chills, headache and eye pain, very achy back, exhausted feeling.  Temp 103.8.  Took 600 mg Advil and ice chips and juice.  Temp down to 102.8. Next day (Sun) temp of 102.2 - 102.8 all day, with 600 mg Advil every 6 hours.  Monday fever of 100.5 - 101.8 all day.  Tuesday (today) fever of 99.5 - 100.5 all day.
The patient received a varicella vaccine in the subQ space on the back of her right arm. The next day it started itching. The patient returned to employee health on the next day and there was redness and swelling in that area.
Red raised hot reaction that started about 2 in x 4 in and grew throughout day to cover almost entire upper arm.
Stated by mother child fainted in office was lethargic and vomited at home x 1 x 24 hours.
within 10 minutes of vaccine. I became nauseous, vertigo.  BP 86/87 HR 90 I became very itchy all over & I asked for Benadryl. I was taken to the ED dept. I was given zofran  4mg and Meclizine for vertigo and IV after 4 hrs. I Was told to go home and sleep it off.  I've home with joint pain, muscle aches, nausea, abdominal pain, foggy mind, tiredness, weakness. Saw my PCP today.  Rest, zofran and meclizine  PRN hydration and rest.
Outside of dosing interval from first and second dose; She was diagnosed with COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (She was diagnosed with COVID-19) and PRODUCT DOSE OMISSION ISSUE (Outside of dosing interval from first and second dose) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PHENYTOIN SODIUM (DILANTIN [PHENYTOIN SODIUM]) and OXCARBAZEPINE (TRILEPTAL) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced COVID-19 (She was diagnosed with COVID-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Outside of dosing interval from first and second dose). At the time of the report, COVID-19 (She was diagnosed with COVID-19) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Outside of dosing interval from first and second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were provided.
Dose administered to a 14 year old/Moderna COVID-19 vaccine was administered to a consumer under the age of 18; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dose administered to a 14 year old/Moderna COVID-19 vaccine was administered to a consumer under the age of 18) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.   No Medical History information was reported.   On 18-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dose administered to a 14 year old/Moderna COVID-19 vaccine was administered to a consumer under the age of 18). On 18-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dose administered to a 14 year old/Moderna COVID-19 vaccine was administered to a consumer under the age of 18) had resolved.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  No concomitant medications were provided. Treatment information was not provided.
Pt felt dizzy and fell, when we helped her up, she started to complain about throat pain. She was given benadryl 25mg and EMS arrived and took her by ambulance.
Itchy body rash starting 5/12/21 and muscle soreness at injection site the day of the vaccine.
?Out of it?  Confusion, Memory loss,  Seeing ?things ?  almost like a Mini stroke